CEACAM5 and non-small cell lung carcinoma: A serum 6-miRNA panel combined with CEA increased discrimination accuracy (AUC) for all-stage and Stage I NSCLC patients from healthy subjects compared to CEA (0.58, 0.53): 0.71 for miR-29c + CEA, 0.71 for miR-429 + CEA, and 0.80 for miR-29c + miR-429 + CEA in all-stage NSCLC; 0.76 for miR-29c + CEA, 0.66 for miR-429 + CEA, and 0.83 for miR-29c + miR-429 + CEA in Stage I NSCLC [102].